I'm not sure that Bene would be at the negotiating table. Their contract is with PAR, not the Pharma. PAR is the middle man who will end up having 2 separate contracts, 1 (existing) with Bene. 1 (TBA) with Pharma.
Bene are a manufacturer, they manufacture Zilosul for PAR, PAR pay them a small commission on sales, that's it as far as I recall?
Chart, page-2397
-
- There are more pages in this discussion • 1,898 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
24.5¢ |
Change
-0.010(3.92%) |
Mkt cap ! $85.70M | |||
| Open | High | Low | Value | Volume |
| 24.5¢ | 25.0¢ | 24.0¢ | $59.66K | 241.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 78837 | 24.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 25.0¢ | 36290 | 1 |
View Market Depth
| Last trade - 16.10pm 30/08/2024 (20 minute delay) ? |
| PAR (ASX) Chart |